Zevra therapeutics to participate in the h.c. wainwright 25th annual global investment conference

Celebration, fla., sept. 05, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a rare disease therapeutics company, today announced that executive management will present at the h.c. wainwright 25th annual global investment conference on wednesday, september 13, 2023, at 8:30 a.m. et. members of zevra's management team will be available for one-on-one investor meetings with registered attendees during the conference from september 11-13, 2023.
ZVRA Ratings Summary
ZVRA Quant Ranking